ACON חוב כולל להון Aclarion

This price evolution chart demonstrates the performance of Aclarion (ACON), which delegates AI data storage to cloud providers to develop its algorithms. The current value of the metric is 0.00. The company's growth is driven by the implementation of the Nociscan system for back pain analysis and the expansion of SaaS services. The digitalization of medical archives via AI technologies reduces energy costs and paper consumption, supporting ESG principles.

For Aclarion (ACON), with its patented MRI diagnostics, the level of debt capital determines the company's ability to await the implementation of insurance reimbursement protocols without the risk of bankruptcy. By analyzing the debt-to-equity ratio trend, an investor assesses total liabilities relative to equity: an increasing ratio signals rising financial leverage, while a decrease confirms business autonomy and high balance sheet stability.